• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为醛糖还原酶抑制剂的酚类海洋天然产物。

Phenolic marine natural products as aldose reductase inhibitors.

作者信息

Manzanaro Sonia, Salva Javier, de la Fuente Jesús Angel

机构信息

Instituto Biomar, S.A., Polígono Industrial, Edificio CEEI, 24231 Onzonilla, León, Spain.

出版信息

J Nat Prod. 2006 Oct;69(10):1485-7. doi: 10.1021/np0503698.

DOI:10.1021/np0503698
PMID:17067167
Abstract

Four different types of marine natural compounds isolated from tunicates were found to inhibit human aldose reductase. They all are characterized by a heterocyclic system, and at least two phenolic groups are present in the structure. Two of the compounds tested showed an inhibitory potency 5/6-fold higher than that of the known AR inhibitor sorbinil. One notable structural feature of these active compounds is the lack of either the carboxylic acid or the spiro-hydantoin commonly present in the principal classes of currently used inhibitors.

摘要

从被囊动物中分离出的四种不同类型的海洋天然化合物被发现可抑制人醛糖还原酶。它们都具有杂环系统的特征,并且结构中至少存在两个酚羟基。所测试的两种化合物显示出比已知的醛糖还原酶抑制剂索比尼尔高5/6倍的抑制效力。这些活性化合物的一个显著结构特征是缺乏目前常用抑制剂主要类别中常见的羧酸或螺环乙内酰脲。

相似文献

1
Phenolic marine natural products as aldose reductase inhibitors.作为醛糖还原酶抑制剂的酚类海洋天然产物。
J Nat Prod. 2006 Oct;69(10):1485-7. doi: 10.1021/np0503698.
2
Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.新型天然酚类海洋抑制剂与醛糖还原酶结合的对接及分子动力学研究
J Mol Graph Model. 2009 Sep;28(2):162-9. doi: 10.1016/j.jmgm.2009.06.003. Epub 2009 Jun 21.
3
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.醛糖还原酶抑制剂治疗糖尿病周围神经病变:综述。
J Diabetes Complications. 2010 Sep-Oct;24(5):354-60. doi: 10.1016/j.jdiacomp.2009.07.005. Epub 2009 Sep 11.
4
[Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor].[糖尿病微血管病变药物治疗进展:醛糖还原酶抑制剂]
Nihon Rinsho. 2005 Jun;63 Suppl 6:127-35.
5
Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.新型醛糖还原酶抑制剂M16209和M16287与已知抑制剂ONO - 2235和索比尼尔的性质比较
Chem Pharm Bull (Tokyo). 1991 Jun;39(6):1540-5. doi: 10.1248/cpb.39.1540.
6
Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).新型依帕司他类似物的合成及作为醛糖还原酶抑制剂(ARIs)的生物评价。
Eur J Med Chem. 2014 Jan;71:53-66. doi: 10.1016/j.ejmech.2013.10.043. Epub 2013 Nov 6.
7
Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.醛糖还原酶抑制剂在人醛糖还原酶活性位点结合模式的分子模拟研究
Bioorg Med Chem. 1998 Oct;6(10):1811-9. doi: 10.1016/s0968-0896(98)00139-4.
8
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.6,7-二羟基-4-苯基香豆素作为醛糖还原酶 2 的抑制剂。
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5630-3. doi: 10.1016/j.bmcl.2010.08.038. Epub 2010 Aug 12.
9
Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).醛酮还原酶超家族成员 AKR1B10 和 AKR1B1 之间的抑制剂选择性:色氨酸 112(色氨酸 111)的作用。
FEBS Lett. 2013 Nov 15;587(22):3681-6. doi: 10.1016/j.febslet.2013.09.031. Epub 2013 Oct 4.
10
X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.V301L 醛酮还原酶 1B10 与 NADP(+) 复合物的 X 射线结构及强效醛糖还原酶抑制剂非达司他的结合:对抑制剂结合和选择性的影响。
Chem Biol Interact. 2013 Feb 25;202(1-3):178-85. doi: 10.1016/j.cbi.2012.12.013. Epub 2013 Jan 4.

引用本文的文献

1
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.膳食多酚在2型糖尿病管理和治疗中的保护作用
Nutrients. 2025 Jan 13;17(2):275. doi: 10.3390/nu17020275.
2
Natural Bioactive Compounds from Marine Invertebrates That Modulate Key Targets Implicated in the Onset of Type 2 Diabetes Mellitus (T2DM) and Its Complications.来自海洋无脊椎动物的天然生物活性化合物,其可调节与2型糖尿病(T2DM)发病及其并发症相关的关键靶点。
Pharmaceutics. 2023 Sep 14;15(9):2321. doi: 10.3390/pharmaceutics15092321.
3
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms.
食物多酚与 II 型糖尿病:药理学与机制
Molecules. 2023 May 10;28(10):3996. doi: 10.3390/molecules28103996.
4
5-[(1,3-Dimethyl-5-oxo-2-sulfanylideneimidazolidin-4-yl-idene)amino]-2-methyl-isoindoline-1,3-dione.5-[(1,3-二甲基-5-氧代-2-硫代亚烷基咪唑烷-4-亚基)氨基]-2-甲基异吲哚啉-1,3-二酮
IUCrdata. 2021 Apr 9;6(Pt 4):x210322. doi: 10.1107/S2414314621003229. eCollection 2021 Apr.
5
Molecular Insight into Gene Response of Diorcinol- and Rubrolide-Treated Biofilms of the Emerging Pathogen Stenotrophomonas maltophilia.深入了解新兴病原体嗜麦芽寡养单胞菌中二烯醇和红古豆醇处理生物膜的基因反应的分子机制。
Microbiol Spectr. 2022 Jun 29;10(3):e0258221. doi: 10.1128/spectrum.02582-21. Epub 2022 Apr 26.
6
Inhibition of Aldose Reductase by Ginsenoside Derivatives via a Specific Structure Activity Relationship with Kinetics Mechanism and Molecular Docking Study.通过构效关系、动力学机制和分子对接研究,抑制醛糖还原酶的人参皂苷衍生物。
Molecules. 2022 Mar 25;27(7):2134. doi: 10.3390/molecules27072134.
7
Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.海洋药物磷乙神经酰胺通过双重靶向 PTP1B 和醛糖还原酶治疗 2 型糖尿病:一种有前景的策略。
Mar Drugs. 2021 Sep 24;19(10):535. doi: 10.3390/md19100535.
8
Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.亨廷顿舞蹈症中的糖基化:一种可能的修饰因素及干预靶点
J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.
9
Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.海洋被囊动物(被囊类;海鞘纲)的天然产物多样性及临床开发中的成功药物
Nat Prod Bioprospect. 2017 Feb;7(1):1-111. doi: 10.1007/s13659-016-0115-5. Epub 2017 Jan 17.
10
Advancements in tetronic acid chemistry. Part 2: Use as a simple precursor to privileged heterocyclic motifs.四特ronic酸化学的进展。第2部分:用作特殊杂环基序的简单前体。
Mol Divers. 2016 Nov;20(4):989-999. doi: 10.1007/s11030-016-9683-x. Epub 2016 Jun 27.